The German drugmaker confirmed acquisition talks, but cautioned a deal may not materialize. Elsewhere, Biohaven got priority review on a key drug and Third Harmonic restructured.

In the future, AI will combine with other advancing technologies to create a new wave of personalized AI capable of ...

Here are the best tax software deals to shop at Amazon.

Yahoo News provides the latest updates on the spread of bird flu in the U.S., and its effect on rising egg prices and ...

The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed ...

Biohaven boasts a robust pipeline with late-stage molecules, but a Hold rating reflects its high market cap and uncertain ...

When people survive catastrophic events such as wildfires or hurricanes, and then are left to cope with loss, they may ...

The "Spatial Proteomics market - Global industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering. The Spatial Proteomics Market ...

According to the child advocacy organization Enough Abuse, 37 states have criminalized AI-generated or AI-modified CSAM, either by amending existing child sexual abuse material laws or enacting new ...

Booking Holdings is a leading online travel company with a $160 billion market cap, showing solid financial position and long ...

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...

Mark Hartley examines the knock-on effect that Trump tariffs could have on the UK stock market and considers a stock that ...